Jama Pitman - 16 Jun 2022 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Jun 2022
Net transactions value
-$13,954
Form type
4
Filing time
21 Jun 2022, 16:36:37 UTC
Previous filing
18 Feb 2022
Next filing
19 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale $13,954 -1,298 -3.4% $10.75 36,661 16 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.

Remarks:

Title: SVP, Regulatory, Quality, & Portfolio Management